Skip to main content
. 2015 Jun 15;2015(6):CD007402. doi: 10.1002/14651858.CD007402.pub3

Sarzi‐Puttini 2014.

Methods R, DB, AC, parallel group, non‐inferiority study
Duration 7 days
Participants Acute musculoskeletal injury (mainly muscular, joint, tendon)
N = 697
M 271, F 426
Mean age 52 years
Interventions Ketoprofen (SKP‐021) patch, ketoprofen 30 mg
Diclofenac (Voltadola), patch diclofenac sodium 140 mg
Patches applied twice daily for 7 days
Outcomes ≥ 50% reduction in PI from baseline to end of study (100 mm VAS)
Patient overall rating
Clinical symptoms (4‐point scale)
Time to response
Adverse events, skin reactions
Serious adverse events
Notes "The analysis of the data of this trial showed that the two formulations were equally effective and well tolerated in the treatment of acute musculoskeletal injuries."

AC: active‐controlled; DB: double‐blind; F: female; M: male; N: number of participants in study; PC: placebo‐controlled; PGE: Patient Global Evaluation of treatment; PI: pain intensity; R: randomised; VAS: visual analogue scale.